CRON FY 2025 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$193M+64.4% YoY

Gross Profit

$63M32.5% margin

Operating Income

-$3M-1.5% margin

Net Income

-$9M-4.9% margin

EPS (Diluted)

$-0.02

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$151,611

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$54M

Stockholders' Equity

$1.1B

Cash & Equivalents

$792M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$193M	$118M	+64.4%
Gross Profit	$63M	$25M	+149.1%
Operating Income	-$3M	-$77M	+96.2%
Net Income	-$9M	$41M	-123.0%